These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 18588458

  • 1. Intraperitoneal chemotherapy: standard of care for patients with minimal residual stage III ovarian cancer?
    Tummala MK, Alagarsamy S, McGuire WP.
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1135-47. PubMed ID: 18588458
    [Abstract] [Full Text] [Related]

  • 2. Evidence-based research for intraperitoneal chemotherapy in epithelial ovarian cancer.
    Almadrones L.
    Clin J Oncol Nurs; 2007 Apr; 11(2):211-6. PubMed ID: 17573270
    [Abstract] [Full Text] [Related]

  • 3. [Intraperitoneal chemotherapy for ovarian cancer].
    Noma J, Yoshida N.
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):885-90. PubMed ID: 18633214
    [Abstract] [Full Text] [Related]

  • 4. [Intraperitoneal chemotherapy in ovarian carcinoma].
    Piura B.
    Harefuah; 2001 Sep; 140(9):844-9, 894, 893. PubMed ID: 11579736
    [Abstract] [Full Text] [Related]

  • 5. [Importance of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer].
    Ferron G, Martinez A, Mery E, Querleu D, Thomas F, Chatelut E, Gladieff L.
    Bull Cancer; 2009 Dec; 96(12):1243-52. PubMed ID: 19948452
    [Abstract] [Full Text] [Related]

  • 6. Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?
    Petignat P, du Bois A, Bruchim I, Fink D, Provencher DM.
    Crit Rev Oncol Hematol; 2007 May; 62(2):137-47. PubMed ID: 17188887
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer.
    Royer B, Delroeux D, Guardiola E, Combe M, Hoizey G, Montange D, Kantelip JP, Chauffert B, Heyd B, Pivot X.
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):415-21. PubMed ID: 17503047
    [Abstract] [Full Text] [Related]

  • 12. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
    Ozols RF.
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247
    [Abstract] [Full Text] [Related]

  • 13. Investigational agents for epithelial ovarian cancer.
    Muggia F, Kosloff R.
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):855-68. PubMed ID: 16221055
    [Abstract] [Full Text] [Related]

  • 14. [Pharmacological bases of intraperitoneal chemotherapy].
    Gladieff L, Chatelut E, Dalenc F, Ferron G.
    Bull Cancer; 2009 Dec; 96(12):1235-42. PubMed ID: 19923051
    [Abstract] [Full Text] [Related]

  • 15. Intraperitoneal chemotherapy: a reemerging approach in the treatment of ovarian cancer.
    Drake B.
    J Infus Nurs; 2009 Dec; 32(6):314-22. PubMed ID: 19918140
    [Abstract] [Full Text] [Related]

  • 16. New and emerging intraperitoneal (IP) drugs for ovarian cancer treatment.
    Muggia FM.
    Semin Oncol; 2006 Dec; 33(6 Suppl 12):S18-24. PubMed ID: 17223446
    [Abstract] [Full Text] [Related]

  • 17. Intraperitoneal chemotherapy in the management of malignant disease.
    Markman M.
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):142-8. PubMed ID: 12113122
    [Abstract] [Full Text] [Related]

  • 18. An update on the use of intraperitoneal chemotherapy in the management of ovarian cancer.
    Markman M.
    Cancer J; 2009 Jun; 15(2):105-9. PubMed ID: 19390303
    [Abstract] [Full Text] [Related]

  • 19. [Report of nationwide questionnaire: intraperitoneal chemotherapy for advanced ovarian cancer based on clinical results--reports of 5th "Gynecologic Intraperitoneal Chemotherapy Study Group" meeting].
    Umezawa S, Shimizu Y, Takizawa K, Nishimura H, Hatae M, Sasaki K, Yoshikawa H.
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1305-11. PubMed ID: 8831743
    [Abstract] [Full Text] [Related]

  • 20. An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
    Berry E, Matthews KS, Singh DK, Buttin BM, Lurain JR, Alvarez RD, Schink J.
    Gynecol Oncol; 2009 Apr; 113(1):63-7. PubMed ID: 19201457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.